SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?


To: David Bogdanoff who wrote (1131)11/2/1999 11:41:00 PM
From: Scott H. Davis  Respond to of 1972
 
Vical Announces Third-Quarter 1999 Financial Results
biz.yahoo.com

PS, I realized that about the orphan drug designation being associated with the indication, not the med, perhaps I did not phrase well earlier. Scott



To: David Bogdanoff who wrote (1131)11/3/1999 5:00:00 PM
From: Scott H. Davis  Read Replies (1) | Respond to of 1972
 
Vical Receives $2 Million Payment From Merck biz.yahoo.com



To: David Bogdanoff who wrote (1131)11/22/1999 7:57:00 PM
From: Scott H. Davis  Read Replies (1) | Respond to of 1972
 
Nice pop & 52 week high today on no news I can find, more surprising since VICL recently moved up from the 13-15 range. Any insight? They've now broken out of all declining trendlines. Scott